Penny Stock

What Is In Future For Antares Pharma

June 20, 2010

One of my preferred simple stock investing techniques for individual investors is to put your retirement wealth in a growing stock. That sounds pretty simple, but many investors quickly understand it’s not as simple an investing plan as it appears — particularly when it arrives to finding hot penny stocks to buy now. After all, [...]

Read the full article →

Planet Nutrition Becomes GT Legend Automotive

March 9, 2010

One may be wondering the connection between Nutrition and Automotive parts. If anyone can guess the relation between these two, please explain to us. GT Legend Automotive Holding’s(GTLA.PK) website shows some ads, may be they found a new way of generating revenue. The company profiles states that GT Legend Automotive, Inc., focuses on the development [...]

Read the full article →

Review of Best Online Brokers

November 22, 2009

Which is the best online share broker? There are too many parameters to consider to find the best online broker. One broker may be charging a little less, but the support may not be good. Another one may have a lousing trading plateform. The software (website ) may not be userfriendly. We will evaluate few online share brokers on different aspects. Trading share online can be very profitable. How ever you have to choose best broker for best results.

Read the full article →

Bright Future for BioElectronics Corporation

November 21, 2009

This is where BioElectronics Corporation(BIEL.PK) scores. Their disposable drug-free anti-inflammatory devices proved to be significantly more effective than acetaminophen in a clinical study of Delayed Onset Muscle Soreness (DOMS). The study tested the effectiveness of ActiPatch Therapy versus acetaminophen in reducing the pain of Delayed Onset Muscle Soreness, a condition associated with increased physical exertion.

Read the full article →

Novavax Starts H1N1 Vaccine Study

October 20, 2009

Vaccine maker Novavax initiated a clinical study of H1N1 swine flew vaccine in mexico. this study will evaluate safety, immunogenicity and efficacy of the virus like particle vaccine, says Novavax in a statement.

Avimex, which is funding the trial, is expected to market the vaccine in Mexico if approved. GE health care will support the study by providing its single-use bio-processing technologies for vaccine production.

Read the full article →

← Previous Entries